Involvement of commensal bacteria may lead to dysregulated inflammatory and autoimmune responses in a mouse model for chronic nonsuppurative destructive cholangitis

Journal of Clinical Immunology

Volumn 32, Issue 5, 2012, Pages 1026-1037

  Haruta, Ikuko ^a   Kikuchi, Ken ^b   Nakamura, Minoru ^c   Hirota, Katsuhiko ^d   Kato, Hidehito ^a   Miyakawa, Hiroshi ^e   Shibata, Noriyuki ^a   Miyake, Yoichiro ^d   Hashimoto, Etsuko ^a   Shiratori, Keiko ^a   Yagi, Junji ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e TEIKYO UNIVERSITY   (Japan)

Author keywords

Autophagy; Bacteria; Chronic nonsuppurative destructive cholangitis (CNSDC); Gp210; Innate immunity; Primary biliary cirrhosis (PBC)

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GP 210; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; AUTOPHAGOSOME; AUTOPHAGY; BACTERIAL STRAIN; CELL INFILTRATION; CELL STRUCTURE; CHOLANGITIS; CHRONIC NONSUPPURATIVE DESTRUCTIVE CHOLANGITIS; COMMENSAL; CYTOPLASM; FEMALE; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; INOCULATION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLEEN CELL; STREPTOCOCCUS INTERMEDIUS;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, ANTINUCLEAR; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FEMALE; LIVER CIRRHOSIS, BILIARY; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; NUCLEAR PORE COMPLEX PROTEINS; SPLEEN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS INTERMEDIUS;

EID: 84866730182     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9712-1     Document Type: Article

References (56)

1. Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev. 2007; 220:251-69.
2. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. New Engl J Med. 2005; 353:1261-73.
3. Portmann BC, Nakanuma Y. Disease of the bile ducts. In: MacSween RNM, Burt AD, Portmann BC, Ishak KG, Scheuer PJ, Anthony PP, editors. Pathology of the liver: London, United Kingdom. Churchill Livingstone; 2002. p. 435-506.
4. Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J. Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis. 2005; 25(3):298-310.
5. Nishio A, Keeffe EB, Gershwin ME. Immunopathogenesis of primary biliary cirrhosis. Semin Liver Dis. 2002; 22(3):291-302.
6. Fussey SP, Ali ST, Guest JR, Bassendine MF, Yeaman SJ. Reactivity of primary biliary cirrhosis with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci. 1990; 87(10):3987-91.
7. Selmi C, Gershwin ME. Bacteria and human autoimmunity: the case of primary biliary cirrhosis. Curr Opin Rheumatol. 2004; 16:406-10.
8. Bogdanos DP, Baum H, Grasso A, Okamoto M, Butler P, Ma Y, et al. Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol. 2004; 40(1):31-9.
9. Bogdanos D, Pusl T, Rust C, Vergani D, Beuers U. Primary biliary cirrhosis following lactobacillus vaccination for recurrent vaginitis. J Hepatol. 2008; 49(3):466-73.
10. Bogdanos DP, Baum H, Okamoto M, Montalto P, Sharma UC, Rigopoulou EI, et al. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its lactobacillus mimic. Hepatology. 2005; 42:458-65.
11. Bogdanos DP, Vergani D. Bacteria and primary biliary cirrhosis. Clinic Rev Allerg Immunol. 2009; 36:30-9.
12. Selmi C, Balkwill DL, Invernizzi P, Ansari AA, Coppel RL, Podda M, et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology. 2003; 38(5):1250-7.
13. Kaplan MM. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am J Gastroenterol. 2004; 99:2147-9.
14. Harada K, Tsuneyama K, Sudo Y, Masuda S, Nakanuma Y. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is propionibacterium acnes involved in granuloma formation? Hepatology. 2001; 33:530-6.
15. Hiramatsu K, Harada K, Tsuneyama K, Sasaki M, Fujita S, Hashimoto T, et al. Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis. J Hepatol. 2000; 33(1):9-18.
16. Wang AP, Migita K, Ito M, Takii Y, Daikoku M, Yokoyama T, et al. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. J Autoimmun. 2005; 25(1):85-91.
17. Yokoyama T, Komori A, Nakamura M, Takii Y, Kamihira T, Shimoda S, et al. Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int. 2006; 26(4):467-76.
18. Moritoki Y, Lian ZX, Wulff H, Yang GX, Chuang YH, Lan RY, et al. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology. 2007; 45(2):314-22.
19. Shimoda S, Harada K, Niiro H, Yoshizumi T, Soejima Y, Taketomi A, et al. Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells. Hepatology. 2008; 47 (3):958-65.
20. Mao TK, Lian ZX, Selmi C, Ichiki Y, Ashwood P, Ansari AA, et al. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis. Hepatology. 2005; 42 (4):802-8.
21. Mells GF, Floyd JAB, Morley KI, Cordell HJ, Franklin CS, Shin S-Y, et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat Genetics. 2011; 43 (4):329-32.
22. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med. 2009; 360:2544-55.
23. Liu X, Invernizzi P, Lu Y, Kosoy R, Lu Y, Bianchi I, et al. Genome-wide meta-analyses identify three loci associated with primary iliary cirrhosis. Nat Genet. 2010; 42(8):658-60.
24. Hirschfield GM, Liu X, Han Y, Gorloy IP, Lu Y, Xu C, et al. Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. Nat Genet. 2010; 42(8):655-7.
25. Haruta I, Hashimoto E, Kato Y, Kikuchi K, Kato H, Yagi J, et al. Lipoteichoic acid may affect the pathogenesis of bile duct damage in primary biliary cirrhosis. Autoimmunity. 2006; 39:129-35.
26. Haruta I, Kikuchi K, Hashimoto E, Kato H, Hirota K, Kobayashi M, et al. A possible role of histone-like DNA-binding protein of Streptococcus intermedius in the pathogenesis of bile duct damage in primary biliary cirrhosis. Clin Immunol. 2008; 127(2):245-51.
27. Selmi C, Diana A, Cocchi CA, Zuin M, Gershwin ME. Environmental factors and the induction of autoimmunity in primary biliary cirrhosis. Expert Rev Clin Immunol. 2008; 4(2):239-45.
28. Haruta I, Kikuchi K, Hashimoto E, Nakamura M, Miyakawa H, Hirota K, et al. Long-term bacterial exposure can trigger non-suppurative destructive cholangitis associated with multifocal epithelial inflammation. Lab Invest. 2010; 90(4):577-88.
29. Yanagisawa N, Haruta I, Kikuchi K, Shibata N, Yagi J. Are Dysregulated Inflammatory Responses to Commensal Bacteria involved in the Pathogenesis of Hepato-Biliary-Pancreatic Autoimmune Disease? An Analysis Using Mice Models of Primary Biliary Cirrhosis and Autoimmune Pancreatitis. ISRN Gastroenterology, ID 513514, 2011.
30. Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011; 469:323-35.
31. Tanaka A, Borchers AT, Ishiashi H, Ansari AA, Keen CL, Gershwin ME. Genetic and familial considerations of primary biliary cirrhosis. Am J Gastroenterol. 2001; 96:8-15.
32. Selmi C, Mayo MJ, Bach N, Ishibashi H, Invernizzi P, Gish RG, Gordon SC, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology. 2004; 127(2):485-92.
33. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 1992; 68:855-67.
34. Williams JA, Hathcock KS, Klug D, Harada Y, Choudhury B, Alison JO, et al. Regulated costimulation in the thymus is critical for T cell development: dysregulated CD28 costimulation can bypass the pre-TCR checkpoint. J Immunol. 2005; 175:4199-207.
35. Nakamura M, Shimizu-Yoshida Y, Takii Y, Komori A, Yokoyama T, Ueki T, et al. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol. 2005; 42:386-92.
36. Bogdanos DP, Invernizzi P, Mackay IR, Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol. 2008; 14(21):3374-87.
37. Bannai M, Oya H, Kawamura T, Naito T, Shimizu T, Kawamura H, et al. Disparate effect of beige mutation on cytotoxic function between natural killer and natural killer T cells. Immunology. 2000; 100:165-9.
38. Jones DE. Autoantigens in primary biliary cirrhosis. J Clin Pathol. 2000; 53:813-21.
39. Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthhington J, et al. Antinuclear antibodies giving the 'multiple nuclear dots' or the 'rim-like/membranous' patterns: diagnostic accuracy for primary biliary cirrhosis. Aliment Pharmacol Ther. 2006; 24:1575-83.
40. Max EE. Immunogulobulins: molecular genetics. In: Paul WE, editor. Fundamental immunology. Philaderphia: Lippincott Williams and Wilkins; 2008. p. 203-4.
41. Selmi C, Mackay IR, Gershwin ME. The autoimmunity of primary biliary cirrhosis and the clonal selection theory. Immunol Cell Biol. 2011; 89:70-80.
42. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology. 2008; 47:737-45.
43. Xu Y, Jagannath C, Liu X, Sharafkhaneh A, Kolodziejska KE, Eissa NT. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity. 2007; 27:135-44.
44. Levine B, Kionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 2004; 6:463-77.
45. Levine B. Eating oneself and uninvited guest: autophagy-related pathways in cellular defense. Cell. 2005; 120:159-62.
46. Kirkegaard K, Taylor MP, Jackson WT. Cellular autophagy: surrender, avoidance, and subversion by microorganisms. Nat Rev Microbiol. 2004; 2:301-14.
47. Nakagawa I, Amano A, Mizushima N, Yamamoto A, Yamaguchi H, Kimimoto T, et al. Autophagy defends cells against invading group A Streptococcus. Science. 2004; 306:1037-40.
48. He XS, Ansari AA, Ridggway WM, et al. New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell Immunol. 2006; 239:1-13.
49. Hamada S, Umemura M, Shiono T, Tanaka K, Yahagi A, Begum MD, et al. IL-17A produced by γδ T cells play a critical role in innate immunity against listeria monocytogenes infection in the liver. J Immunol. 2008; 181:3456-63.
50. Nemeth E, Baird AW, O'Farrey C. Microanatomy of the liver immune system. Semin Immunopathol. 2009; 31:333-43.
51. Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, He X-S, et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using human CD1d tetramer. Gastroenterology. 2002; 123:1031-43.
52. Mattner J, Savage PB, Leung P, Oertelt Ss, Wang V, Trivedi O, et al. Liver autoimmunity triggered by microbial activation of natural killer T cells. Cell Host & Microbe. 2008; 3:304-15.
53. Jin N, Miyahara N, Roark CL, French JD, Aydintug MK, Matsuda JL, et al. Airway hyperresponsiveness through synergy of γδ T cells and NKT cells. J Immunol. 2007; 179:2961-68.
54. Lleo A, Invernizzi P, Mackay IR, Prince H, Zhong R-Q, Gershwin ME. Etiopathogenesis of primary biliary cirrhosis. World J Gastroenterol. 2008; 14(21):3328-37.
55. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today. 1993; 14(9):426-30.
56. Haruta I, Yanagisawa N, Kawamura S, Furukawa T, Shimizu K, Kato H, et al. A mouse model of autoimmune pancreatitis with salivary gland involvement triggered by innate immunity via persistent exposure to avirulent bacteria. Lab Invest. 2010; 90(12):1757-69.